Form 8-K - Current report:
SEC Accession No. 0001193125-16-738145
Filing Date
2016-10-14
Accepted
2016-10-14 07:17:02
Documents
3
Period of Report
2016-10-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d267493d8k.htm 8-K 19030
2 EX-99.1 d267493dex991.htm EX-99.1 8645
3 EX-99.2 d267493dex992.htm EX-99.2 8584
  Complete submission text file 0001193125-16-738145.txt   37659
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 161935954
SIC: 2836 Biological Products, (No Diagnostic Substances)